No abstract available
MeSH terms
-
Acquired Immunodeficiency Syndrome / prevention & control*
-
Clinical Trials as Topic
-
England
-
HIV Antigens / adverse effects*
-
Humans
-
Peptides / adverse effects*
-
Vaccination*
-
gag Gene Products, Human Immunodeficiency Virus
Substances
-
HGP-30 peptide, Human immunodeficiency virus-1
-
HIV Antigens
-
Peptides
-
gag Gene Products, Human Immunodeficiency Virus